IRCT20130812014333N168招募中2 期
Comparison of the renoprotective effects of SGLT2 inhibitor (Empagliflozin) in diabetic and non-diabetic kidney transplantation patients during a clinical trial at Imam Reza Educational and Medical Center in Kermanshah
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Urinary protein excretion less than (<) 500 mg to 3500 mg / g in a 24-hour urine set
- •Kidney transplant equal to or greater than 1 year ago
- •Stable state of renal function for at least the last three months
- •Sustained immunosuppressive therapy for at least the last 3 months
排除标准
- •Creatinine above 2
- •Patients who are pregnant or are breastfeeding
- •Patients with a history of type 1 diabetes
- •History of more than one kidney transplant; History of severe allergies or contraindications to empagliflozin
- •History of recurrent urinary tract infection
研究者
相似试验
已完成
3 期
Evaluation Renoprotective Effect SGLT2 inhibitors on Prognosis of Transplant Kidney PatientsCondition 1: Diabetes mellitus type 2. Condition 2: Transplant Kidney.Type 2 diabetes mellitus with kidney complicationsKidney transplant statusE11.2Z94.0IRCT20220708055414N1Orchidpharmed30
招募中
不适用
Investigation of renal protective effects of SGLT2 inhibitor by using renal doppler ultrasonographyJPRN-UMIN000028438Ogawa Red Cross Hospital60
已完成
不适用
ong-term renoprotective effect of SGLT2 inhibitorstype 2 diabetes melllitusJPRN-UMIN000034387ephrology Division, JA Toride Medical Center60
招募中
不适用
Cardio- and nephroprotective mechanisms of SGLT2 inhibitioI50.1N18Left ventricular failureChronic kidney diseaseDRKS00031101niversitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin II383
Unknown
4 期
Effect of SGLT2 inhibitor on Renal Function and Urinary [TIMP-2] x [IGFBP7] in Patients Hospitalized for Acute Heart Failure; A Randomized Controlled TrailAcute kidney injury and urinary [TIMP-2] x [IGFBP7] in patient hospitalized for acute heart failureAcute kidney injury, urinary [TIMP-2] x [IGFBP7], nephrocheck, acute heart failure, acute decompensated heart failure, SGLT2 inhibitor, renal function, biomarkerTCTR20221003002/A66